A couple of weeks ago South African medical experts informed the world that they have identified a new Corona Virus (Covid-19) variant called the Omicron variant, and the Omicron Covid-19 variant has since been detected in countless countries around the world.
According to reports, the Omicron Covid-19 variant is a currently a major influence in the alarming increase of Corona Virus cases in South Africa, and unfortunately a young lady named Sheila recently tested positive for the Omicron Covid-19 variant.
Sheila took to her official Twitter account earlier today (Monday 6 December) to share a picture of the medications that she bought to treat herself after testing positive for the Omicron Covid-19 variant, hopefully Sheila's medication works for her and other people..
"So I tested positive for Omicron I hope these meds work 🥺
Symptoms: headache and joints pains, no flu no coughing just body ache" - She wrote.
Content created and supplied by: ProudlySouthAfricanNews (via Opera News )
Opera News is a free to use platform and the views and opinions expressed herein are solely those of the author and do not represent, reflect or express the views of Opera News. Any/all written content and images displayed are provided by the blogger/author, appear herein as submitted by the blogger/author and are unedited by Opera News. Opera News does not consent to nor does it condone the posting of any content that violates the rights (including the copyrights) of any third party, nor content that may malign, inter alia, any religion, ethnic group, organization, gender, company, or individual. Opera News furthermore does not condone the use of our platform for the purposes encouraging/endorsing hate speech, violation of human rights and/or utterances of a defamatory nature. If the content contained herein violates any of your rights, including those of copyright, and/or violates any the above mentioned factors, you are requested to immediately notify us using via the following email address operanews-external(at)opera.com and/or report the article using the available reporting functionality built into our Platform See More